Tumour Necrosis Factor Inhibitors and Infection: What Is there to Know for Infectious Diseases Physicians?
At this year's meeting of Digestive Disease Week in Los Angeles, California, it was noted that antitumour necrosis factor (anti-TNF) inhibitors showed further evidence of efficacy in Crohn's disease (1). TNF antagonists have been used increasingly in the treatment of a number of other infl...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2006-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2006/385789 |